 | ||||||
ABOUT USScience-based treatment solutions since 1997 In a market overflowing with promises, “Clinically proven” is more than an empty claim at Ellipse. Incontrovertible scientific evidence has stood behind every Ellipse solution since the first Ellipse system made its debut in 1997. And today, Ellipse has an international reputation for advanced technology, impeccable quality and comprehensive customer support. Application areas include treatment of acne, sun-damaged skin, hair removal, skin resurfacing, wrinkle reduction and the removal of pigmented and vascular lesions. Every Ellipse product is developed in close cooperation with leading dermatologists and research institutions. The Ellipse Clinical Advisory Board, comprising respected dermatologists from around the world, plays a key role in product development, as does input from focus groups and customers. With thousands of users and millions of treatments around the world and scores of clinical articles documenting the safety and effectiveness of Ellipse products, Ellipse is indeed CLINICALLY PROVEN, SAFE AND EFFECTIVE. | ||||||
Vision Ellipse wants to be the end customers’ preferred partner supplying innovative, clinically proven, safe and effective solutions founded on light-based skin treatments. History Ellipse A/S was founded in 1997 under the name Danish Dermatologic Development A/S. In 1998 a distribution network was established, and today Ellipse A/S distributes products to more than 50 countries world wide. In 2002 Ellipse GmbH was established in Germany, and in 2007 Ellipse also started direct sales in Spain and the US. The first product to be launched was the Ellipse Flex System and later the Ellipse Light followed. Ellipse today Ellipse A/S engages more than 70 employees. The headquarters in Denmark develops, manufactures and markets high-quality laser and IPL based systems for dermatologic treatments of a wide variety of medical and cosmetic conditions. Ellipse is among the top-providers of IPL and laser solutions, and possesses a strong IP position with world wide IPL licenses. Ellipse is owned by Axcel, Denmark’s largest investment company, with combined revenues of more than $2 billion. |
| |||||
 | | |
 | |||
| | | |
| |||
| Login | |||
| |